JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB87977

Anti-MGAT5 antibody [3E9]

4

(5 Reviews)

|

(8 Publications)

Mouse Monoclonal MGAT5 antibody. Carrier free. Suitable for Flow Cyt, WB and reacts with Human, Recombinant fragment - Human samples. Cited in 8 publications. Immunogen corresponding to Recombinant Fragment Protein within Human MGAT5 aa 600 to C-terminus.

View Alternative Names

GGNT5, MGAT5, GlcNAc-T V, Mannoside acetylglucosaminyltransferase 5, N-acetylglucosaminyl-transferase V, GNT-V

4 Images
Flow Cytometry - Anti-MGAT5 antibody [3E9] (AB87977)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-MGAT5 antibody [3E9] (AB87977)

Overlay histogram showing Jurkat cells stained with ab87977 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab87977, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-mouse IgG (H&L) (ab150113) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in Jurkat cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

This image was generated using the ascites version of the product.

Western blot - Anti-MGAT5 antibody [3E9] (AB87977)
  • WB

Unknown

Western blot - Anti-MGAT5 antibody [3E9] (AB87977)

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-MGAT5 antibody [3E9] (ab87977) at 1 µg/mL

All lanes:

jurkat cell lysate at 25 µg

Secondary

All lanes:

Goat Anti-Mouse IgG (H&L)-HRP Conjugate at 1/2500 dilution

Predicted band size: 85 kDa

false

Western blot - Anti-MGAT5 antibody [3E9] (AB87977)
  • WB

AbReview51060****

Western blot - Anti-MGAT5 antibody [3E9] (AB87977)

Blocking was via 5% milk in PBST incubated for 1 hour at 22°C

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-MGAT5 antibody [3E9] (ab87977) at 1/2000 dilution

All lanes:

Human RWPE prostate cells at 20 µg

Secondary

All lanes:

Donkey anti-mouse polyclonal HRP conjugate at 1/10000 dilution

Predicted band size: 85 kDa

Observed band size: 55 kDa,95 kDa

true

Exposure time: 40s

Image is courtesy of an AbReview submitted by Armen Petrosyan.

Western blot - Anti-MGAT5 antibody [3E9] (AB87977)
  • WB

Unknown

Western blot - Anti-MGAT5 antibody [3E9] (AB87977)

The recombinant protein used as the immunogen has a predicted size of 37 kDa.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-MGAT5 antibody [3E9] (ab87977) at 1 µg/mL

All lanes:

recombinant protein fragment with a proprietary tag (the immunogen) at 0.1 µg

Secondary

All lanes:

Goat Anti-Mouse IgG (H&L)-HRP Conjugate at 1/5000 dilution

Predicted band size: 85 kDa

Observed band size: 37 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

3E9

Isotype

IgG2a

Light chain type

kappa

Carrier free

Yes

Reacts with

Human

Applications

Flow Cyt, WB

applications

Immunogen

Recombinant Fragment Protein within Human MGAT5 aa 600 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q09328

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg2c-kappa-monoclonal-18c8bc7ad10-isotype-control-ab170191'>ab170191</a> - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" }, "Mouse": { "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Recombinant fragment - Human": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 15 May 2019. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Purification notes
Purified from TCS.
Storage buffer
pH: 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MGAT5 also known as beta-16-N-acetylglucosaminyltransferase V or GnT-V is an enzyme with a molecular mass of approximately 83 kDa. This enzyme plays a role in the Golgi apparatus where it modifies N-glycans on glycoproteins by adding N-acetylglucosamine to N-glycans. MGAT5 is expressed in various tissues including the brain liver and kidneys. Its enzymatic function is essential in creating complex branched glycan structures influencing the cellular surface glycosylation patterns.
Biological function summary

MGAT5 contributes to cellular processes such as cell-cell communication cell migration and signal transduction. These processes are important in tissues where it is expressed. MGAT5 is not part of a complex but works closely with other glycosyltransferases in the glycosylation pathway. Its glycan products interact with lectins and receptors on the cell surface influencing signaling pathways and cellular behavior.

Pathways

MGAT5 is significant in the glycosylation pathway and the PI3K/AKT signaling pathway. In these pathways MGAT5 modifies glycoproteins which can impact receptor function and downstream signaling. It interacts with proteins such as integrins and growth factor receptors affecting cellular responses to environmental cues and influencing growth and differentiation signals.

MGAT5 is associated with cancer progression and autoimmune diseases. Altered MGAT5 expression and activity in cancer cells can promote tumor growth and metastasis by enhancing cell invasion and evasion mechanisms. The enzyme links to proteins like TGF-beta receptor and E-cadherin in cancer contributing to the changes in cellular adhesion and signaling that facilitate metastasis. In autoimmune diseases MGAT5 modulates immune cell function impacting disease progression and severity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the addition of N-acetylglucosamine (GlcNAc) in beta 1-6 linkage to the alpha-linked mannose of biantennary N-linked oligosaccharides (PubMed : 10395745, PubMed : 30140003). Catalyzes an important step in the biosynthesis of branched, complex-type N-glycans, such as those found on EGFR, TGFR (TGF-beta receptor) and CDH2 (PubMed : 10395745, PubMed : 22614033, PubMed : 30140003). Via its role in the biosynthesis of complex N-glycans, plays an important role in the activation of cellular signaling pathways, reorganization of the actin cytoskeleton, cell-cell adhesion and cell migration. MGAT5-dependent EGFR N-glycosylation enhances the interaction between EGFR and LGALS3 and thereby prevents rapid EGFR endocytosis and prolongs EGFR signaling. Required for efficient interaction between TGFB1 and its receptor. Enhances activation of intracellular signaling pathways by several types of growth factors, including FGF2, PDGF, IGF, TGFB1 and EGF. MGAT5-dependent CDH2 N-glycosylation inhibits CDH2-mediated homotypic cell-cell adhesion and contributes to the regulation of downstream signaling pathways. Promotes cell migration. Contributes to the regulation of the inflammatory response. MGAT5-dependent TCR N-glycosylation enhances the interaction between TCR and LGALS3, limits agonist-induced TCR clustering, and thereby dampens TCR-mediated responses to antigens. Required for normal leukocyte evasation and accumulation at sites of inflammation (By similarity). Inhibits attachment of monocytes to the vascular endothelium and subsequent monocyte diapedesis (PubMed : 22614033).. Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A. Promotes proliferation of umbilical vein endothelial cells and angiogenesis, at least in part by promoting the release of the growth factor FGF2 from the extracellular matrix.
See full target information MGAT5

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Journal of translational internal medicine 13:281-294 PubMed40896287

2025

N-acetylglucosaminyltransferase V attenuates myocardial infarction by mediating the insulin-like growth factor 1 receptor signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Tianqi Chang,Yangya'nan Jin,Chenyu Fan,Hu Wang,Ling Jin,Yidan Shi,Houhua Li,Jiaxing Wang,Ming Xu

Nutrition & metabolism 21:53 PubMed39080739

2024

Inhibition of N-acetylglucosaminyltransferase V alleviates diabetic cardiomyopathy in mice by attenuating cardiac hypertrophy and fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Ran Zhao,Jianqiang Hu,He Wen,Jieqiong Zhao,Ying Wang,Xiaona Niu,Mingming Zhang,Tingting Wang,Yan Li

Frontiers in oncology 13:1133476 PubMed37256183

2023

RUNX2 promotes gastric cancer progression through the transcriptional activation of MGAT5 and MMP13.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Wang,Zhibo Tan,Xiaoyu Li,Lili Zhang,Xiaojuan Pei

Journal of cellular biochemistry 124:797-807 PubMed37062903

2023

Inhibition of N-glycosylation by glucosamine hydrochloride inhibits TGF-β1-induced LOXL2 secretion.

Applications

Unspecified application

Species

Unspecified reactive species

Tetsuro Kamiya,Mai Kadowaki,Taku Atobe,Kana Kunieda,Koki Morimoto,Hirokazu Hara

Journal of cellular physiology 237:1780-1789 PubMed34806177

2021

Overexpression of N-acetylglucosaminyltransferase V promotes human parotid gland acinar cell immortalization via the epidermal receptor activation.

Applications

Unspecified application

Species

Unspecified reactive species

Ching-Chia Cheng,Chih-Feng Lin,Yong-Chong Lin,Tai-Horng Young,Pei-Jen Lou

Experimental and therapeutic medicine 21:128 PubMed33376510

2020

Silencing GnT-V reduces oxaliplatin chemosensitivity in human colorectal cancer cells through N-glycan alteration of organic cation transporter member 2.

Applications

Unspecified application

Species

Unspecified reactive species

Xi Cong,Xingwan Liu,Xiaopeng Dong,Shuoshuo Fang,Zheng Sun,Jianhui Fan

American journal of cancer research 9:585-596 PubMed30949412

2019

Decreased miR-124-3p promoted breast cancer proliferation and metastasis by targeting MGAT5.

Applications

Unspecified application

Species

Unspecified reactive species

Guiling Yan,Yinhui Li,Lu Zhan,Shuhan Sun,Jihang Yuan,Tiantian Wang,Yupeng Yin,Zhihui Dai,Yiqing Zhu,Zhijing Jiang,Lin Liu,Yinxing Fan,Fu Yang,Wei Hu

Oncotarget 8:71867-71880 PubMed29069753

2017

Loss of Barx1 promotes hepatocellular carcinoma metastasis through up-regulating MGAT5 and MMP9 expression and indicates poor prognosis.

Applications

Unspecified application

Species

Unspecified reactive species

Guodong Wang,Jian Liu,Yi Cai,Jie Chen,Wenbing Xie,Xiangqian Kong,Wenjie Huang,Hao Guo,Xiaodi Zhao,Yuanyuan Lu,Lu Niu,Xiaowei Li,Haijia Zhang,Chao Lei,Zhijie Lei,Jipeng Yin,Hao Hu,Fan Yu,Yongzhan Nie,Limin Xia,Kaichun Wu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com